The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.675
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.05 (7.692%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.675
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks rise as market sentiment recovers

Tue, 04th Oct 2022 08:46

(Alliance News) - Stock prices in London opened sharply higher on Tuesday, lifted by more positive market sentiment following the UK government's tax U-turn, as well as some positive trading updates.

The FTSE 100 index opened up 73.28 points, 1.1%, at 6,982.04. The FTSE 250 opened up 274.82 points, 1.6%, at 17,558.98 and the AIM All-Share opened up 6.51 points, 0.8% at 815.24.

The Cboe UK 100 opened up 1.3%% at 699.00, the Cboe UK 250 opened up 1.2% at 14,965.48, and the Cboe Small Companies opened 0.1% higher at 12,758.68.

In European equities on Tuesday, the CAC 40 in Paris opened up 2.2%, while the DAX 40 in Frankfurt opened up 2.0%.

Liz Truss has stressed she must take a "responsible" approach to the public finances, as she faces a Cabinet split and a fresh battle with Tory rebels fighting real-terms cuts to benefits.

The prime minister is refusing to rule out a return to austerity or say whether welfare payments will be increased in line with soaring inflation.

Critics who forced a U-turn over the plan to abolish the 45 pence tax rate for top earners are now stepping up pressure on the government to confirm benefits will be raised.

Meanwhile, the Conservative Party Conference continues in Birmingham.

Keynote speeches by Home Secretary Suella Braverman and Foreign Secretary James Cleverly will aim to set out the government's plans on immigration and commitment to support Ukraine.

As discontent brews within the party, Priti Patel is set to accuse Truss and Kwarteng of "spending today with no thought of tomorrow".

"I want to see our party regain its credibility by restoring its commitment to sustainable public spending...which is affordable today, tomorrow and for the foreseeable future," the former home secretary will tell a conference fringe event, according to The Times.

"The UK government's decision to reverse part of its previous tax-cutting plan also had a disproportionately positive effect on sentiment generally, with sterling recouping some of its previously precipitous losses following the initial announcement," interactive investor's Head of Markets Richard Hunter said.

The pound was quoted at USD1.1365 at the London equities open Tuesday, continuing to rise from USD1.1309 at the close on Monday.

Hunter added: "Nonetheless, the longer term impact of the attempt to stimulate growth is yet to be proven, while the government's initial announcement seemed at odds with what the Bank of England is trying to achieve."

In the FTSE 100, Legal & General added 4.7% in early trading.

The financial services firm said it has maintained positive momentum from the first half into the second, "despite market volatility", which has had a "limited economic impact" on the firm. L&G said it expects to deliver annual operating profit growth in line with the 8% seen in the first half.

It said recent "extraordinary" interest rate hikes have been challenging for its pension fund clients and counterparties of its Investment Management liability-driven investment business. However, recent purchases of long-dated gilts by the Bank of England have helped to alleviate the pressure.

Its annuity portfolio continues to perform well, and "has not experienced any difficulty in meeting collateral calls and we have not been forced sellers of gilts or bonds", it said.

L&G estimates a solvency coverage ratio between 235% to 240% as at September 30.

In the FTSE 250, Greggs gained 6.0%.

The pastry chain said total sales were up 15% for the 13 weeks to October 1, and backed its full-year expectations.

It continues to expect around 150 net shop openings in 2022, and left its cost inflation outlook unchanged for the year at around 9%.

"As expected, year-on-year growth moderated in August given the particularly strong 'staycation' effect seen in 2021, however, momentum returned in September. We closed our shops on September 19 for the funeral of Her Majesty The Queen and this impacted reported LFL sales growth for the third quarter by around one percentage point," the food-to-go seller noted.

It acknowledged "considerable" economic uncertainty but expects full-year results to be in line with previous expectations.

Royal Mail rose 3.1%, as its name change to International Distributions Services takes effect. It was first announced back in July.

Wizz Air rose 2.8%, after sharing significant annual growth in September. The budget airline said passengers in the month were up 52% year-on-year to 4.5 million, as capacity rose 37% to 5.3 million.

Ryanair also put in a good performance in the month, with guests rising 49% year-on-year to 15.9 million, and load factor improving to 94% from 81% a year prior. Its shares were up 2.5% in Dublin.

On AIM, N4 Pharma was 12% higher as it reported the successful in vitro testing of Nuvec, its novel delivery system for cancer treatments and vaccines.

Poolbeg Pharma rose 6.0%. The pharmaceutical firm said the US Patent & Trademarks Office has indicated that its patent application "that is directed to the use of POLB 001 and its homologues for the treatment of hypercytokinemia" is allowable.

It expects the formal patent grant in due course, and has filed a continuing application to protect additional claims around this indication.

The euro stood at USD0.9871, up against USD0.9834 at the same time on Monday.

Against the yen, the dollar was trading at JPY144.67, higher compared to JPY144.35 late Monday.

Brent oil was quoted at USD89.38 a barrel at the London equities open Tuesday, up from USD88.30 late Monday.

Gold was quoted at USD1,706.10 an ounce Tuesday, higher against USD1,690.38 at the close on Monday.

Stocks in the Asia Pacific region were stronger on Tuesday. The Nikkei 225 in Tokyo closed up 3.0%, while the S&P/ASX 200 in Sydney ended up 3.8%, after an unexpectedly dovish move from its central bank.

"Australia injected some hope into the region, as its central bank lifted interest rates by just 0.25%, rather less than expected, and prompting wider hopes that other monetary authorities might also consider such a wait and see approach," said ii's Richard Hunter.

In China, financial markets were closed as National Day Golden Week continues.

Still to come in the day's economic calendar, there's EU producer inflation at 1000 BST, and comments from US Federal Reserve officials later in the day.

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
25 Mar 2020 12:15

N4 Pharma Explores Nuvec's Potential In Covid-19 Vaccine Delivery

N4 Pharma Explores Nuvec's Potential In Covid-19 Vaccine Delivery

Read more
24 Mar 2020 15:49

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
25 Feb 2020 11:42

N4 Pharma Annual Loss Narrows Amid Work To Improve Nuvec System

N4 Pharma Annual Loss Narrows Amid Work To Improve Nuvec System

Read more
25 Feb 2020 08:49

N4 Pharma narrows loss as it continues development work

(Sharecast News) - Specialist pharmaceutical company N4 Pharma reported a smaller operating loss for 2019 on Tuesday, at ?0.95m, compared to ?1.42m in the prior year.

Read more
11 Feb 2020 14:19

N4 Pharma shares rise on partnership with Nanomerics

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has signed a 14-month research collaboration with Nanomerics to produce and test two candidate formulations using its 'Nuvec' delivery system, it announced on Tuesday.

Read more
11 Feb 2020 11:37

N4 Pharma Signs Research Collaboration Agreement With Nanomerics

N4 Pharma Signs Research Collaboration Agreement With Nanomerics

Read more
18 Sep 2019 12:04

N4 Pharma Interim Loss Widens After Non-Repeat Of Grant, Disposal Gain

(Alliance News) - N4 Pharma PLC on Wednesday said its loss widened slightly in the first half of the year, owing to grant income and a gain on an investment sale the year before which did not in a

Read more
20 Aug 2019 11:49

N4 Pharma Repeats Study And Finds Nuvec Successful At "Certain Doses"

(Alliance News) - N4 Pharma PLC on Tuesday said it has repeated the in-vivo study of Nuvec and shown it does work "when using multiple injections at certain doses".Shares in N4 at

Read more
19 Jun 2019 13:38

N4 Pharma To Start Experiments On Nuvec; Results Due In Two Months

(Alliance News) - N4 Pharma PLC on Wednesday said it will begin experiments on its Nuvec system on Friday this week with results due in around two months.Shares in N4 were up 20% at 4.30 in

Read more
12 Jun 2019 16:04

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 JuneTescoWM Morrison SupermarketsSirius MineralsJust Jack 14 Evans 17 18

Read more
21 May 2019 13:25

N4 Pharma Appoints John Chiplin as Non-Executive Chairman

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said it appointed John Chiplin as non-executive chair of the company with immediate effect.Furthermore, the pharmaceutical firm appointed a

Read more
14 May 2019 12:09

N4 Pharma Loss Narrowed By Cost; Will Explore Assets Outside Nuvec

LONDON (Alliance News) - N4 Pharma PLC on Tuesday reported a narrowed loss for 2018 on lower costs and said it is exploring new opportunities while continuing work on core Nuvec drug delivery in -

Read more
15 Apr 2019 15:33

N4 Pharma reassures shareholders over future of 'Nuvec'

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated the market on the development of 'Nuvec' on Monday, following the disclosure of inconsistencies in the efficacy of Nuvec between various in vitro and in vivo studies.

Read more
15 Apr 2019 15:20

N4 Pharma Finds Issues With In Vivo Nuvec Testing And Plans Repeat

LONDON (Alliance News) - N4 Pharma PLC on Monday said it has become aware of a number of issues with the in vivo studies of its Nuvec delivery system.On Tuesday last week, N4 announced of a

Read more
9 Apr 2019 11:27

N4 Pharma Shares Sink As Nuvec Fails To Produce Response In-Vivo

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said early in-vivo tests of its Nuvec delivery system did not match positive results from in-vitro tests, causing shares to slump.Shares in

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.